<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Novaccess Global Inc — News on 6ix</title>
<link>https://6ix.com/company/novaccess-global-inc</link>
<description>Latest news and press releases for Novaccess Global Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 21 May 2024 13:28:23 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/novaccess-global-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835dc6b78dffbe2df1244b1.webp</url>
<title>Novaccess Global Inc</title>
<link>https://6ix.com/company/novaccess-global-inc</link>
</image>
<item>
<title>NovAccess Global Files Patent with Cedars-Sinai to Advance its Brain Cancer Fighting Vaccine Platform</title>
<link>https://6ix.com/company/novaccess-global-inc/news/novaccess-global-files-patent-with-cedars-sinai-to-advance-its-brain-cancer-fighting-vaccine-platform</link>
<guid isPermaLink="true">https://6ix.com/company/novaccess-global-inc/news/novaccess-global-files-patent-with-cedars-sinai-to-advance-its-brain-cancer-fighting-vaccine-platform</guid>
<pubDate>Tue, 21 May 2024 13:28:23 GMT</pubDate>
<description>NovAccess Global Files Patent with Cedars-Sinai to Advance its Brain Cancer Fighting Vaccine Platform.</description>
</item>
<item>
<title>NovAccess Global Advisory on Annual Meeting of Shareholders</title>
<link>https://6ix.com/company/novaccess-global-inc/news/novaccess-global-advisory-on-annual-meeting-of-shareholders</link>
<guid isPermaLink="true">https://6ix.com/company/novaccess-global-inc/news/novaccess-global-advisory-on-annual-meeting-of-shareholders</guid>
<pubDate>Tue, 07 May 2024 15:58:17 GMT</pubDate>
<description>NovAccess Global Advisory on Annual Meeting of Shareholders.</description>
</item>
<item>
<title>NovAccess Global Announces New License to Advance its Immunotherapy Platform</title>
<link>https://6ix.com/company/novaccess-global-inc/news/novaccess-global-announces-new-license-to-advance-its-immunotherapy-platform</link>
<guid isPermaLink="true">https://6ix.com/company/novaccess-global-inc/news/novaccess-global-announces-new-license-to-advance-its-immunotherapy-platform</guid>
<pubDate>Tue, 30 Apr 2024 13:06:01 GMT</pubDate>
<description>NovAccess Global Announces New License to Advance its Immunotherapy Platform.</description>
</item>
<item>
<title>NovAccess Global Provides Business Updates and Announces Scheduling of Annual Meeting of Shareholders</title>
<link>https://6ix.com/company/novaccess-global-inc/news/novaccess-global-provides-business-updates-and-announces-scheduling-of-annual-meeting-of-shareholders</link>
<guid isPermaLink="true">https://6ix.com/company/novaccess-global-inc/news/novaccess-global-provides-business-updates-and-announces-scheduling-of-annual-meeting-of-shareholders</guid>
<pubDate>Fri, 01 Mar 2024 14:04:06 GMT</pubDate>
<description>NovAccess Global Provides Business Updates and Announces Scheduling of Annual Meeting of Shareholders.</description>
</item>
<item>
<title>NovAccess Global Announces $10.7 Million Financing</title>
<link>https://6ix.com/company/novaccess-global-inc/news/novaccess-global-announces-dollar107-million-financing</link>
<guid isPermaLink="true">https://6ix.com/company/novaccess-global-inc/news/novaccess-global-announces-dollar107-million-financing</guid>
<pubDate>Tue, 02 Jan 2024 13:02:29 GMT</pubDate>
<description>NovAccess Global Announces $10.7 Million Financing.</description>
</item>
<item>
<title>NovAccess Global Appoints Dr. Roscoe M. Moore, Jr. to Scientific Advisory Board</title>
<link>https://6ix.com/company/novaccess-global-inc/news/novaccess-global-appoints-dr-roscoe-m-moore-jr-to-scientific-advisory-board</link>
<guid isPermaLink="true">https://6ix.com/company/novaccess-global-inc/news/novaccess-global-appoints-dr-roscoe-m-moore-jr-to-scientific-advisory-board</guid>
<pubDate>Fri, 10 Nov 2023 14:02:10 GMT</pubDate>
<description>NovAccess Global Appoints Dr. Roscoe M. Moore, Jr. to Scientific Advisory Board.</description>
</item>
<item>
<title>NovAccess Global Partners with BCN Biosciences to Expand Immunotherapy Platform</title>
<link>https://6ix.com/company/novaccess-global-inc/news/novaccess-global-partners-with-bcn-biosciences-to-expand-immunotherapy-platform</link>
<guid isPermaLink="true">https://6ix.com/company/novaccess-global-inc/news/novaccess-global-partners-with-bcn-biosciences-to-expand-immunotherapy-platform</guid>
<pubDate>Thu, 27 Jul 2023 12:31:31 GMT</pubDate>
<description>NovAccess Global Partners with BCN Biosciences to Expand Immunotherapy Platform.</description>
</item>
<item>
<title>NovAccess Global to Participate in National Brain Tumor Society's Annual Glioblastoma Awareness Day</title>
<link>https://6ix.com/company/novaccess-global-inc/news/novaccess-global-to-participate-in-national-brain-tumor-societys-annual-glioblastoma-awareness-day</link>
<guid isPermaLink="true">https://6ix.com/company/novaccess-global-inc/news/novaccess-global-to-participate-in-national-brain-tumor-societys-annual-glioblastoma-awareness-day</guid>
<pubDate>Thu, 13 Jul 2023 12:31:47 GMT</pubDate>
<description>NovAccess Global to Participate in National Brain Tumor Society's Annual Glioblastoma Awareness Day.</description>
</item>
<item>
<title>NovAccess Global Partners with CKN Ventures to Expand its New AI-driven Precision Medicine Division</title>
<link>https://6ix.com/company/novaccess-global-inc/news/novaccess-global-partners-with-ckn-ventures-to-expand-its-new-ai-driven-precision-medicine-division</link>
<guid isPermaLink="true">https://6ix.com/company/novaccess-global-inc/news/novaccess-global-partners-with-ckn-ventures-to-expand-its-new-ai-driven-precision-medicine-division</guid>
<pubDate>Fri, 16 Jun 2023 16:40:30 GMT</pubDate>
<description>NovAccess Global Partners with CKN Ventures to Expand its New AI-driven Precision Medicine Division.</description>
</item>
<item>
<title>NovAccess Global Launches Precision Medicine Division Using AI, Big Data and Predictive Technologies to Accelerate Personalized Healthcare Therapies</title>
<link>https://6ix.com/company/novaccess-global-inc/news/novaccess-global-launches-precision-medicine-division-using-ai-big-data-and-predictive-technologies-to-accelerate-personalized-healthcare-therapies</link>
<guid isPermaLink="true">https://6ix.com/company/novaccess-global-inc/news/novaccess-global-launches-precision-medicine-division-using-ai-big-data-and-predictive-technologies-to-accelerate-personalized-healthcare-therapies</guid>
<pubDate>Thu, 01 Jun 2023 12:41:41 GMT</pubDate>
<description>NovAccess Global Launches Precision Medicine Division Using AI, Big Data and Predictive Technologies to Accelerate Personalized Healthcare Therapies.</description>
</item>
<item>
<title>NovAccess Global Lead Scientist Published in High-Profile Medical Journal for Cancer Vaccine Advancements</title>
<link>https://6ix.com/company/novaccess-global-inc/news/novaccess-global-lead-scientist-published-in-high-profile-medical-journal-for-cancer-vaccine-advancements</link>
<guid isPermaLink="true">https://6ix.com/company/novaccess-global-inc/news/novaccess-global-lead-scientist-published-in-high-profile-medical-journal-for-cancer-vaccine-advancements</guid>
<pubDate>Thu, 11 May 2023 13:07:56 GMT</pubDate>
<description>NovAccess Global Lead Scientist Published in High-Profile Medical Journal for Cancer Vaccine Advancements.</description>
</item>
<item>
<title>Dr. Christopher Wheeler, NovAccess Lead Scientist, Receives Prestigious Golden Axon Award</title>
<link>https://6ix.com/company/novaccess-global-inc/news/dr-christopher-wheeler-novaccess-lead-scientist-receives-prestigious-golden-axon-award</link>
<guid isPermaLink="true">https://6ix.com/company/novaccess-global-inc/news/dr-christopher-wheeler-novaccess-lead-scientist-receives-prestigious-golden-axon-award</guid>
<pubDate>Wed, 15 Mar 2023 13:00:58 GMT</pubDate>
<description>Dr. Christopher Wheeler, NovAccess Lead Scientist, Receives Prestigious Golden Axon Award.</description>
</item>
<item>
<title>NovAccess Global to Present at World Orphan Drug Congress</title>
<link>https://6ix.com/company/novaccess-global-inc/news/novaccess-global-to-present-at-world-orphan-drug-congress</link>
<guid isPermaLink="true">https://6ix.com/company/novaccess-global-inc/news/novaccess-global-to-present-at-world-orphan-drug-congress</guid>
<pubDate>Thu, 16 Feb 2023 14:01:57 GMT</pubDate>
<description>NovAccess Global to Present at World Orphan Drug Congress.</description>
</item>
<item>
<title>NovAccess Global Leadership to Present at World Brain Mapping Foundation Annual Congress</title>
<link>https://6ix.com/company/novaccess-global-inc/news/novaccess-global-leadership-to-present-at-world-brain-mapping-foundation-annual-congress</link>
<guid isPermaLink="true">https://6ix.com/company/novaccess-global-inc/news/novaccess-global-leadership-to-present-at-world-brain-mapping-foundation-annual-congress</guid>
<pubDate>Fri, 03 Feb 2023 14:01:02 GMT</pubDate>
<description>NovAccess Global Leadership to Present at World Brain Mapping Foundation Annual Congress.</description>
</item>
<item>
<title>NovAccess Global Announces Fireside Chat with Dr. Christopher Wheeler, the Company’s Lead Scientist and President of its StemVax Therapeutics Division</title>
<link>https://6ix.com/company/novaccess-global-inc/news/novaccess-global-announces-fireside-chat-with-dr-christopher-wheeler-the-companys-lead-scientist-and-president-of-its-stemvax-therapeutics-division</link>
<guid isPermaLink="true">https://6ix.com/company/novaccess-global-inc/news/novaccess-global-announces-fireside-chat-with-dr-christopher-wheeler-the-companys-lead-scientist-and-president-of-its-stemvax-therapeutics-division</guid>
<pubDate>Thu, 05 Jan 2023 17:16:17 GMT</pubDate>
<description>NovAccess Global Announces Fireside Chat with Dr. Christopher Wheeler, the Company’s Lead Scientist and President of its StemVax Therapeutics Division.</description>
</item>
<item>
<title>NovAccess Global Announces Initial Fireside Chat with Glioblastoma Patient Advocate</title>
<link>https://6ix.com/company/novaccess-global-inc/news/novaccess-global-announces-initial-fireside-chat-with-glioblastoma-patient-advocate</link>
<guid isPermaLink="true">https://6ix.com/company/novaccess-global-inc/news/novaccess-global-announces-initial-fireside-chat-with-glioblastoma-patient-advocate</guid>
<pubDate>Tue, 22 Nov 2022 13:01:17 GMT</pubDate>
<description>NovAccess Global Announces Initial Fireside Chat with Glioblastoma Patient Advocate.</description>
</item>
<item>
<title>NovAccess Global Appoints Healthcare IP Consultant Dr. Peter Weinstein to Scientific Advisory Board</title>
<link>https://6ix.com/company/novaccess-global-inc/news/novaccess-global-appoints-healthcare-ip-consultant-dr-peter-weinstein-to-scientific-advisory-board</link>
<guid isPermaLink="true">https://6ix.com/company/novaccess-global-inc/news/novaccess-global-appoints-healthcare-ip-consultant-dr-peter-weinstein-to-scientific-advisory-board</guid>
<pubDate>Thu, 10 Nov 2022 19:02:20 GMT</pubDate>
<description>NovAccess Global Appoints Healthcare IP Consultant Dr. Peter Weinstein to Scientific Advisory Board.</description>
</item>
<item>
<title>NovAccess Global Announces Virtual Annual Shareholders' Meeting</title>
<link>https://6ix.com/company/novaccess-global-inc/news/novaccess-global-announces-virtual-annual-shareholders-meeting</link>
<guid isPermaLink="true">https://6ix.com/company/novaccess-global-inc/news/novaccess-global-announces-virtual-annual-shareholders-meeting</guid>
<pubDate>Tue, 08 Nov 2022 14:01:13 GMT</pubDate>
<description>NovAccess Global Announces Virtual Annual Shareholders' Meeting.</description>
</item>
<item>
<title>NovAccess Global Receives FDA Approval of Orphan Drug Application for TLR-AD1</title>
<link>https://6ix.com/company/novaccess-global-inc/news/novaccess-global-receives-fda-approval-of-orphan-drug-application-for-tlr-ad1</link>
<guid isPermaLink="true">https://6ix.com/company/novaccess-global-inc/news/novaccess-global-receives-fda-approval-of-orphan-drug-application-for-tlr-ad1</guid>
<pubDate>Wed, 26 Oct 2022 17:08:55 GMT</pubDate>
<description>NovAccess Global Receives FDA Approval of Orphan Drug Application for TLR-AD1.</description>
</item>
<item>
<title>NovAccess Global Announces Fireside Chat with Board Member Perspectives</title>
<link>https://6ix.com/company/novaccess-global-inc/news/novaccess-global-announces-fireside-chat-with-board-member-perspectives</link>
<guid isPermaLink="true">https://6ix.com/company/novaccess-global-inc/news/novaccess-global-announces-fireside-chat-with-board-member-perspectives</guid>
<pubDate>Thu, 20 Oct 2022 13:18:11 GMT</pubDate>
<description>NovAccess Global Announces Fireside Chat with Board Member Perspectives.</description>
</item>
</channel>
</rss>